The solitary endoparasitoid Aenasius vexans Kerrich (Hymenoptera: Encyrtidae) is used for augmentative releases against the cassava mealybug, Phenacoccus herreni Cox & Williams (Sternorrhyncha: Pseudococcidae), an important pest on cassava in South America. In light of the need for large numbers of high quality females, experiments were conducted on host stage suitability and sex allocation. In choice and no-choice experiments, individual female wasps were offered second and third instar, as well as adult, hosts. During the first five days after emergence, the wasps showed a steady increase in the number of hosts they successfully parasitised per day, but the respective secondary sex ratio for each instar remained constant. Parasitism was highest for third instar hosts in no-choice tests, while in choice tests parasitism was highest in both third instars and adults. The later the developmental stage of the host at oviposition, the faster the parasitoids developed and emerged, and for each host stage, the development time of males was shorter than for females. The sex ratio of the wasps emerging from hosts that were parasitised as second instars was strongly male-biased, while the apparently preferred later stages yielded significantly more females than males. Female and male A. vexans emerging from hosts parasitised at the third instar were significantly larger than for the other stages. This may explain the preference for the third instar as well as the female-biased sex ratio, as size is usually positively correlated with higher fitness, especially in females. The results suggest that third instar hosts are the most suitable for rearing high numbers of large females.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.